The Efficacy and Safety of Chlorhexidine Gluconate Chip (PerioChip®) in Therapy of Peri-implantitis
Status:
Completed
Trial end date:
2018-11-01
Target enrollment:
Participant gender:
Summary
The objective of the study is to assess the efficacy and safety of PerioChip® (Chlorhexidine
gluconate chip) in the treatment of patients with Peri-implantitis.
The hypothesis of the study is that PerioChip® in adjunct to mechanical subgingival
debridement is more effective in the treatment of peri-implantitis when compared to the
common method of mechanical subgingival debridement alone. The primary efficacy measure will
be the reduction in probing pocket depth at 6 months as measured at sites of qualifying
target implant.